Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy
Status:
Not yet recruiting
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of eupatilin on the prevention of
gastroenteropathy in patients with NSAIDs and low dose steroid by comparing with rebamipide.